Shattuck Labs CEO and Co-Founder to give presentation: CD40 Enhances Type I Interferon Responses Downstream of CD47 Blockade to Bridge Innate and Adaptive ImmunityFor Agenda and Registration go to https://www.pegsummit.com/Immunotherapy-Targets